Fibromyalgia (Fibromyalgia Syndrome) – Global Clinical Trials Review, H2, 2021
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
GlobalData’s clinical trial report provides an overview of the fibromyalgia (Fibromyalgia Syndrome) clinical trials scenario. This report provides top-line data relating to the clinical trials on fibromyalgia (Fibromyalgia Syndrome). The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also provides prominent drugs for in-progress trials (based on several ongoing trials). GlobalData clinical trial reports are generated using GlobalData’s proprietary Pharma clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news, etc across the globe. Clinical trials database undergoes periodic updates by dynamic process.
Fibromyalgia (Fibromyalgia Syndrome) clinical trial report consists of 558 trials. Trials conducted by companies in Phase IV, Phase III, Phase II, Phase I, and Phase 0 stand at 41, 70, 82, 189, and 2 respectively. Similarly, the trials with different status compile of completed – 404, ongoing – 48, planned – 43, suspended – 3, terminated – 26, and withdrawn – 34. Out of 404 completed trials 241 trials have achieved endpoint.
What are the market dynamics of the global fibromyalgia (Fibromyalgia Syndrome) therapeutics clinical trials sector?
The number of fibromyalgia (fibromyalgia syndrome) clinical trials conducted globally, has increased by over 19% for the period 2016- 2020. As of December 2021, out of 404 completed trials, 294 trials have results and 241 trials reached endpoints. During the same period, there were 197 clinical trials in Phase I, of which 7 clinical trials were in progress for the time period of 1995-2021, and 48 clinical trials in progress of which 24 trials were in Phase II study. The trials that were terminated/suspended or withdrawn accounted for 63. This was due to the lack of efficacy, safety, and lack of accrual of subjects.
What are the top regions and countries in the global fibromyalgia (Fibromyalgia Syndrome) therapeutics clinical trials sector?
In total there were 558 clinical trials conducted on fibromyalgia (fibromyalgia syndrome), as of December 2021, of these 190 clinical trials were in North America. During the same period, the US has the highest average patient enrollment in fibromyalgia (Fibromyalgia Syndrome) clinical trials.
North America: The US has the highest number of fibromyalgia (fibromyalgia syndrome) clinical trials followed by Canada and Mexico.
Europe: Among the European countries, Spain has the highest number of fibromyalgia (fibromyalgia syndrome) clinical trials followed by France, Italy, the UK, and Germany.
Asia-Pacific: In the Asia-Pacific region, China has the highest number of fibromyalgia (fibromyalgia syndrome) clinical trials followed by Thailand, South Korea, India, and Japan.
Middle East and Africa: Iran has the highest number of fibromyalgia (fibromyalgia syndrome) clinical trials followed by Israel and South Africa and Egypt.
South and Central America: Brazil has the highest number of fibromyalgia (fibromyalgia syndrome) clinical trials followed by Chile, Argentina, Venezuela, and Colombia.
G7 countries: Among the G7 (The US, the UK Germany, France, Italy, Canada, and Japan) countries, Canada has the highest proportion of fibromyalgia (Fibromyalgia Syndrome) to central nervous system clinical trials as of December 2021. In total there were 301 clinical trials conducted on fibromyalgia (Fibromyalgia Syndrome), in G7 countries, of these 162 clinical trials were in the US. During the same period, there were 23 clinical trials in progress and 185 trials are completed. The trials that are terminated/suspended or withdrawn accounted for 32.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Indonesia has the highest proportion of fibromyalgia (Fibromyalgia Syndrome) to central nervous system clinical trials as of December 2021. In total there were 98 clinical trials conducted on fibromyalgia (Fibromyalgia Syndrome), in E7 countries, of these 32 clinical trials were in China.
Global fibromyalgia (Fibromyalgia Syndrome) therapeutics clinical trials sector, by regions
For more regional insights, download a free report sample
Which are the key companies in the global fibromyalgia (Fibromyalgia Syndrome) therapeutics clinical trials sector?
As of December 2021, Eli Lilly and Co. sponsored the highest number of fibromyalgia (fibromyalgia syndrome) clinical trials followed by Viatris Inc and Pfizer Inc. Other major companies in the sector are Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Co Ltd, Tonix Pharmaceuticals Holding Corp, Syneos Health Inc, UCB SA, Dr. Reddy’s Laboratories Ltd, and C. H. Boehringer Sohn AG & Co KG.
Global fibromyalgia (Fibromyalgia Syndrome) therapeutics clinical trials sector, by key companies
To know more about key companies, download a free report sample
Market report scope
Key countries | The US, the UK, Spain, Canada, China, Germany, Japan, France, Italy, and Belgium |
Key companies | Eli Lilly and Co, Viatris Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Co Ltd, Tonix Pharmaceuticals Holding Corp, Syneos Health Inc, UCB SA, Dr. Reddy’s Laboratories Ltd, and C. H. Boehringer Sohn AG & Co KG. |
Scope
- The report provides a snapshot of the global clinical trials landscape.
- Report provides top-level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type, and End point status.
- The report reviews the top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
- The report provides all the unaccomplished trials (Terminated, Suspended, and Withdrawn) with the reason for unaccomplishment.
- The Report provides enrollment trends for the past five years.
- Report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regard to investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities.
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country-level.
Viatris Inc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Daiichi Sankyo Co Ltd
Tonix Pharmaceuticals Holding Corp
Syneos Health Inc
UCB SA
C. H. Boehringer Sohn AG & Co KG
Dr. Reddy's Laboratories Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key countries in the global fibromyalgia (Fibromyalgia Syndrome) therapeutics clinical trials sector?
Key countries in the global fibromyalgia (Fibromyalgia Syndrome) therapeutics clinical trials sector are the US, the UK, Spain, Canada, China, Germany, Japan, France, Italy, and Belgium.
-
Which are the key companies in the global fibromyalgia (Fibromyalgia Syndrome) therapeutics clinical trials sector?
Key companies in the global fibromyalgia (Fibromyalgia Syndrome) therapeutics clinical trials sectors are Eli Lilly and Co, Viatris Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Co Ltd, Tonix Pharmaceuticals Holding Corp, Syneos Health Inc, UCB SA, Dr. Reddy’s Laboratories Ltd, and C. H. Boehringer Sohn AG & Co KG.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.